Harmony Biosciences (HRMY) News Today $32.90 -0.07 (-0.21%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$33.02 +0.13 (+0.38%) As of 06:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HRMY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Harmony Biosciences (NASDAQ:HRMY) Trading Down 4.5% - Should You Sell?Harmony Biosciences (NASDAQ:HRMY) Shares Down 4.5% - What's Next?June 12, 2025 | marketbeat.com77,867 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by CX InstitutionalCX Institutional purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 77,867 shares of the company's stock, valued at appJune 12, 2025 | marketbeat.comMillennium Management LLC Has $218,000 Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Millennium Management LLC cut its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 91.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 6,333 shares of the company's stock after selling 64,478 shares during the quarter. MillenniJune 12, 2025 | marketbeat.comAnalysts Offer Predictions for HRMY FY2026 EarningsJune 12, 2025 | americanbankingnews.comCantor Fitzgerald Weighs in on HRMY FY2026 EarningsHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Harmony Biosciences in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will post eJune 11, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by California State Teachers Retirement SystemCalifornia State Teachers Retirement System grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 25.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 37,087 shares of the company's stoJune 10, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Bridge City Capital LLCBridge City Capital LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 54.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 160,739 shares of the company's stock after purchasing an additJune 9, 2025 | marketbeat.comHarmony Biosciences Holdings (HRMY) Shares Cross Below 200 DMAJune 7, 2025 | nasdaq.comHarmony Biosciences settles generic drug litigation, strengthens patentJune 6, 2025 | finance.yahoo.comHarmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA LitigationJune 5, 2025 | businesswire.comHennion & Walsh Asset Management Inc. Boosts Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Hennion & Walsh Asset Management Inc. lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 14.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 85,871 shares of the company'June 5, 2025 | marketbeat.comHarmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare ConferenceJune 4, 2025 | businesswire.comGAMMA Investing LLC Raises Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)GAMMA Investing LLC lifted its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 10,618.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 97,214 shares of the compaJune 4, 2025 | marketbeat.comSquarepoint Ops LLC Has $582,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Squarepoint Ops LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 125.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 16,901 shares of the company's stock after purchasing an additional 9,411 shares during the perioJune 4, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $3.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 94,011 shares of the cJune 3, 2025 | marketbeat.com4HRMY : Where Harmony Biosciences Hldgs Stands With AnalystsJune 2, 2025 | benzinga.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest UpdateHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 2,550,000 shares, a decrease of 21.5% from the April 30th total of 3,250,000 shares. Approximately 5.9% of the company's stock are short sold. Based on an average trading volume of 738,700 shares, the days-to-cover ratio is presently 3.5 days.June 2, 2025 | marketbeat.comOppenheimer Begins Coverage on Harmony Biosciences (NASDAQ:HRMY)Oppenheimer started coverage on Harmony Biosciences in a research note on Monday. They issued an "outperform" rating and a $61.00 price objective on the stock.June 2, 2025 | marketbeat.comNuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Nuveen Asset Management LLC lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 4.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 212,351 shares of the coMay 31, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Two Sigma Advisers LPTwo Sigma Advisers LP grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 21.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,900 shares of the company's stockMay 28, 2025 | marketbeat.comBank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Bank of America Corp DE cut its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 35.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 202,508 shares of the company's stock after selling 113,4May 28, 2025 | marketbeat.comAmeriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Ameriprise Financial Inc. increased its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 22.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 103,801 shares of the company's stock afMay 28, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Buy" by AnalystsHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) has been assigned an average recommendation of "Buy" from the nine analysts that are currently covering the company, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating and one has given a stMay 28, 2025 | marketbeat.comTwo Sigma Investments LP Buys 132,595 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Two Sigma Investments LP increased its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 92.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,594 shares of the company's stock after buying anMay 27, 2025 | marketbeat.comVoloridge Investment Management LLC Grows Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Voloridge Investment Management LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 24.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 356,072 shares of tMay 26, 2025 | marketbeat.comRafferty Asset Management LLC Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Rafferty Asset Management LLC purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,105 shareMay 26, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AGDeutsche Bank AG grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 85,949 shares of the company's stock after purchasing an additional 18,939May 24, 2025 | marketbeat.comvenBio Partners LLC Trims Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)venBio Partners LLC reduced its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 539,194 shares of the company's stock after selling 75,400 shares during theMay 22, 2025 | marketbeat.comValor Management LLC Sells 4,600,000 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Valor Management LLC cut its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 41.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,618,033 shares of the company's stock after selling 4,600,000 shares dMay 22, 2025 | marketbeat.comMan Group plc Acquires 58,642 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Man Group plc boosted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 37.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 214,113 shares of the company's stock after buying an additional 58,642 sharesMay 22, 2025 | marketbeat.comNomura Holdings Inc. Has $1.81 Million Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Nomura Holdings Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 187.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,607 shares of the company's stock after acqMay 20, 2025 | marketbeat.comJanus Henderson Group PLC Increases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Janus Henderson Group PLC increased its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 31.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 221,063 shares ofMay 20, 2025 | marketbeat.comBNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)BNP Paribas Financial Markets purchased a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 58,857 shares of the company's stock, valued at approximately $2,025,000May 20, 2025 | marketbeat.comGotham Asset Management LLC Sells 16,220 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Gotham Asset Management LLC reduced its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 24.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 50,502 shares of the company's stock after selling 16,220 sharesMay 19, 2025 | marketbeat.comGraham Capital Management L.P. Acquires Shares of 14,690 Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Graham Capital Management L.P. bought a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 14,690 shares of the company's stock, valued at apprMay 18, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust CorpNorthern Trust Corp boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 37.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 404,462 shares of the company's stock after puMay 18, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor FitzgeraldCantor Fitzgerald raised Harmony Biosciences to a "strong-buy" rating in a research report on Tuesday.May 17, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. raised its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 39.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 313,013 shMay 15, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Holdings Boosted by D. E. Shaw & Co. Inc.D. E. Shaw & Co. Inc. boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 35.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 480,605 shares of the company's stock afterMay 15, 2025 | marketbeat.comJefferies Financial Group Inc. Has $10.52 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Jefferies Financial Group Inc. raised its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 41.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 305,600 shares of the company's stock after acquiring an additional 89,00May 14, 2025 | marketbeat.comWe Like Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings For More Than Just Statutory ProfitMay 13, 2025 | finance.yahoo.comQ2 EPS Forecast for Harmony Biosciences Lowered by AnalystHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Analysts at HC Wainwright reduced their Q2 2025 earnings estimates for shares of Harmony Biosciences in a research report issued to clients and investors on Wednesday, May 7th. HC Wainwright analyst P. Trucchio now forecasts that thMay 13, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stake Lifted by Cresset Asset Management LLCCresset Asset Management LLC raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 11.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 71,765 shares of the company's stock after buying an additional 7,557 shares durinMay 12, 2025 | marketbeat.comAQR Capital Management LLC Has $5.47 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)AQR Capital Management LLC raised its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 11.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 158,856 shares of the company'May 11, 2025 | marketbeat.comDeep Track Capital LP Makes New Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Deep Track Capital LP purchased a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 1,450,000 shares of the company's stock, valued at aMay 9, 2025 | marketbeat.com43,329 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by Brevan Howard Capital Management LPBrevan Howard Capital Management LP bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 43,329 shares of the company's stock, valued at approximaMay 9, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Announces Quarterly Earnings ResultsHarmony Biosciences (NASDAQ:HRMY - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.19. Harmony Biosciences had a net margin of 17.98% and a return on equity of 23.16%. The business's quarterly revenue was up 19.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.67 earnings per share.May 8, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Strong EarningsHarmony Biosciences (NASDAQ:HRMY) Shares Gap Up After Strong EarningsMay 8, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Harmony Biosciences (NASDAQ:HRMY)Needham & Company LLC reissued a "buy" rating and set a $49.00 target price on shares of Harmony Biosciences in a report on Tuesday.May 8, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc Q1 Profit Increases, Beats EstimatesMay 7, 2025 | nasdaq.com Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address HRMY Media Mentions By Week HRMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼1.320.90▲Average Medical News Sentiment HRMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼107▲HRMY Articles Average Week Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Roivant Sciences News Revolution Medicines News BridgeBio Pharma News Elanco Animal Health News Verona Pharma News Legend Biotech News TG Therapeutics News Grifols News Lantheus News Telix Pharmaceuticals Limited American Depositary Shares News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HRMY Stock Free HRMY Stock Alerts